{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The directory 'static/' exists.\n"
     ]
    }
   ],
   "source": [
    "import os \n",
    "\n",
    "directory_path = 'static/'\n",
    "\n",
    "# checking if the directory exists\n",
    "if os.path.exists(directory_path):\n",
    "    print(f\"The directory '{directory_path}' exists.\")\n",
    "else:\n",
    "    print(f\"The directory '{directory_path}' does not exist.\")\n",
    "    os.mkdir(\"static/\")\n",
    "    print(\"Created\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "from PIL import Image\n",
    "import pytesseract\n",
    "import numpy as np \n",
    "import fitz  # for the PDF \n",
    "import PyPDF2\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "Collected at            : Processed at             : LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "SwasthFit Super 4\n",
      "COMPLETE BLOOD COUNT;CBC\n",
      "Hemoglobin\n",
      "(Photometry) 13.00 - 17.00 g/dL 15.00\n",
      "Packed Cell Volume (PCV)\n",
      "(Calculated) 40.00 - 50.00 % 45.00\n",
      "RBC Count\n",
      "(Electrical Impedence) 4.50 - 5.50 mill/mm3 4.50\n",
      "MCV\n",
      "(Electrical Impedence) 83.00 - 101.00 fL 90.00\n",
      "MCH\n",
      "(Calculated) 27.00 - 32.00 pg 32.00\n",
      "MCHC\n",
      "(Calculated) 31.50 - 34.50 g/dL 33.00\n",
      "Red Cell Distribution Width (RDW)\n",
      "(Electrical Impedence) 11.60 - 14.00 % 14.00\n",
      "Total Leukocyte Count  (TLC)\n",
      "(Electrical Impedence) 4.00 - 10.00 thou/mm3 8.00\n",
      "Differential Leucocyte Count (DLC)\n",
      "(VCS Technology)\n",
      " 40.00 - 80.00 Segmented Neutrophils % 60.00\n",
      " 20.00 - 40.00 Lymphocytes % 30.00\n",
      " 2.00 - 10.00 Monocytes % 5.00\n",
      " 1.00 - 6.00 Eosinophils % 5.00\n",
      " <2.00 Basophils % 0.00\n",
      "Absolute Leucocyte Count\n",
      "(Calculated)\n",
      " 2.00 - 7.00 Neutrophils thou/mm3 4.80\n",
      " 1.00 - 3.00 Lymphocytes thou/mm3 2.40\n",
      " 0.20 - 1.00 Monocytes thou/mm3 0.40\n",
      " 0.02 - 0.50 Eosinophils thou/mm3 0.40\n",
      " 0.02 - 0.10 Basophils thou/mm3 0.00\n",
      "Platelet Count\n",
      "(Electrical impedence) 150.00 - 410.00 thou/mm3 200\n",
      "Mean Platelet Volume\n",
      "(Electrical Impedence) 6.5 - 12.0 fL 10.0\n",
      "*439854467*\n",
      ".\n",
      "Page 1 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "Collected at            : Processed at             : LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "Note\n",
      "1. As per the recommendation of International council for Standardization in Hematology, the differential\n",
      "    leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of\n",
      "    blood  \n",
      "                    \n",
      "2. Test conducted on EDTA whole blood\n",
      "*439854467*\n",
      ".\n",
      "Page 2 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "Collected at            : Processed at             : LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "LIVER & KIDNEY PANEL, SERUM\n",
      "0.90 Creatinine\n",
      "(Modified Jaffe,Kinetic) 0.70 - 1.30 mg/dL\n",
      "118 GFR Estimated\n",
      "(CKD EPI Equation 2021) >59 mL/min/1.73m2\n",
      "G1 GFR Category\n",
      "(KDIGO Guideline 2012)  \n",
      "20.00 Urea\n",
      "(Urease UV) 13.00 - 43.00 mg/dL\n",
      "9.34 Urea Nitrogen  Blood\n",
      "(Calculated) 6.00 - 20.00 mg/dL\n",
      "10 BUN/Creatinine Ratio\n",
      "(Calculated)  \n",
      "5.00 Uric Acid\n",
      "(Uricase) 3.50 - 7.20 mg/dL\n",
      "11.0 AST (SGOT)\n",
      "(IFCC without P5P) 15.00 - 40.00 U/L\n",
      "21.0 ALT (SGPT)\n",
      "(IFCC without P5P) 10.00 - 49.00 U/L\n",
      "11.0 GGTP\n",
      "(IFCC) 0 - 73 U/L\n",
      "150.00 Alkaline Phosphatase (ALP)\n",
      "(IFCC-AMP) 30.00 - 120.00 U/L\n",
      "0.20 Bilirubin  Total\n",
      "(Oxidation) 0.30 - 1.20 mg/dL\n",
      "0.10 Bilirubin  Direct\n",
      "(Oxidation) <0.3 mg/dL\n",
      "0.10 Bilirubin  Indirect\n",
      "(Calculated) <1.10 mg/dL\n",
      "7.00 Total Protein\n",
      "(Biuret) 5.70 - 8.20 g/dL\n",
      "4.00 Albumin\n",
      "(BCG) 3.20 - 4.80 g/dL\n",
      "1.33 A : G Ratio\n",
      "(Calculated) 0.90 - 2.00 \n",
      "3.00 Globulin(Calculated)  2.0 - 3.5 gm/dL\n",
      "8.00 Calcium, Total\n",
      "(Arsenazo III) 8.70 - 10.40 mg/dL\n",
      "*439854467*\n",
      ".\n",
      "Page 3 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "Collected at            : Processed at             : LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "4.00 Phosphorus\n",
      "(Molybdate UV) 2.40 - 5.10 mg/dL\n",
      "140.00 Sodium\n",
      "(Indirect ISE) 136.00 - 145.00 mEq/L\n",
      "5.00 Potassium\n",
      "(Indirect ISE) 3.50 - 5.10 mEq/L\n",
      "101.00 Chloride\n",
      "(Indirect ISE) 98.00 - 107.00 mEq/L\n",
      "Note\n",
      "1.Estimated GFR  (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category \n",
      "reported as per KDIGO guideline 2012. \n",
      "2.eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney \n",
      "damage\n",
      "3.The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal \n",
      "azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the \n",
      "BUN/creatinine ratio is about 10:1\n",
      "LIPID SCREEN, SERUM\n",
      "105.00 Cholesterol, Total\n",
      "(CHO-POD) <200.00 mg/dL\n",
      "130.00 Triglycerides\n",
      "(GPO-POD) <150.00 mg/dL\n",
      "46.00 HDL  Cholesterol\n",
      "(Enzymatic Immunoinhibition) >40.00 mg/dL\n",
      "33.00 LDL Cholesterol, Calculated\n",
      "(Calculated) <100.00 mg/dL\n",
      "26.00 VLDL Cholesterol,Calculated\n",
      "(Calculated) <30.00 mg/dL\n",
      "59 Non-HDL Cholesterol\n",
      "(Calculated) <130 mg/dL\n",
      "Note\n",
      "1.Measurements in the same patient can show physiological & analytical variations. Three serial \n",
      "samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.\n",
      "2.Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400 \n",
      "mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400 \n",
      "mg/dL\n",
      "3.Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for \n",
      "*439854467*\n",
      ".\n",
      "Page 4 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "Collected at            : Processed at             : LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be \n",
      "done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk \n",
      "factors\n",
      "4.Indians tend to have higher triglyceride levels & Lower HDL cholesterol combined with small dense \n",
      "LDL particles, a pattern known as atherogenic dyslipidemia\n",
      "5.Non HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL, \n",
      "VLDL & VLDL remnants, Chylomicron remnants & Lp(a)\n",
      "6.LAI recommends LDL cholesterol as primary target and Non HDL cholesterol as co-primary treatment \n",
      "target\n",
      "7.Apolipoprotein B is an, secondary lipid target for treatment once LDL & Non HDL goals have been \n",
      "achieved\n",
      "8.Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2  should be considered among \n",
      "patients with moderate risk for ASCVD for risk refinement\n",
      " \n",
      "Treatment Goals as per Lipid Association of India 2020\n",
      "   --------------------------------------------------------------------------------------------\n",
      "|   RISK     |              TREATMENT GOAL             |             CONSIDER THERAPY        |\n",
      "| CATEGORY   |-----------------------------------------|-------------------------------------|\n",
      "|            | LDL CHOLESTEROL    | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|\n",
      "|            |  (LDL-C)(mg/dL)    | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|\n",
      "|------------|--------------------|--------------------|----------------|--------------------|\n",
      "| Extreme    |       <50          |        <80         |                |                    |\n",
      "| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) |      ≥50       |        ≥80         |\n",
      "| Category A |                    |                    |                |                    |\n",
      "|------------|--------------------|--------------------|----------------|--------------------|\n",
      "| Extreme    |                    |                    |                |                    |\n",
      "| Risk Group |       ≤30          |        ≤60         |      >30       |        >60         |\n",
      "| Category A |                    |                    |                |                    |\n",
      "|------------|--------------------|--------------------|----------------|--------------------|\n",
      "|   Very     |       <50          |        <80         |      ≥50       |        ≥80         |\n",
      "|   High     |                    |                    |                |                    |\n",
      "|------------|--------------------|--------------------|----------------|--------------------|\n",
      "|   High     |       <70          |        <100        |      ≥70       |        ≥100        |\n",
      "|------------|--------------------|--------------------|----------------|--------------------|\n",
      "| Moderate   |       <100         |        <130        |      ≥100      |        ≥130        |\n",
      "|------------|--------------------|--------------------|----------------|--------------------|\n",
      "|    Low     |       <100         |        <130        |      ≥130*     |        ≥160*       |\n",
      " --------------------------------------------------------------------------------------------\n",
      "    *In low risk patient, consider therapy after an initial non-pharmacological intervention for at  \n",
      "     least 3 months\n",
      "*439854467*\n",
      ".\n",
      "Page 5 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "Collected at            :Processed at             :LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD\n",
      "(HPLC, NGSP certified)\n",
      "HbA1c 5.3 % 4.00 - 5.60\n",
      "Estimated average glucose (eAG) 105 mg/dL\n",
      "Interpretation\n",
      "HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic\n",
      "Interpretation as per American Diabetes Association (ADA) Guidelines\n",
      " \n",
      " ------------------------------------------------------------------------------------------\n",
      "| Reference Group | Non diabetic      | At risk       | Diagnosing  | Therapeutic goals    |\n",
      "|                 | adults >=18 years | (Prediabetes) | Diabetes    | for glycemic control |\n",
      "| ----------------|-------------------|---------------|-------------|----------------------|\n",
      "| HbA1c in %      | 4.0-5.6           | 5.7-6.4       | >= 6.5      | <7.0                 |\n",
      " ------------------------------------------------------------------------------------------\n",
      "Note:  Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered, \n",
      "particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.\n",
      " ---------------------------------------------------------------------------------\n",
      "| FACTORS THAT INTERFERE WITH HbA1C    | FACTORS THAT AFFECT INTERPRETATION       |\n",
      "| MEASUREMENT                          | OF HBA1C RESULTS                         |\n",
      "|--------------------------------------|------------------------------------------|\n",
      "| Hemoglobin variants,elevated fetal   | Any condition that shortens erythrocyte  |\n",
      "| hemoglobin (HbF) and chemically      | survival or decreases mean erythrocyte   |\n",
      "| modified derivatives of hemoglobin   | age (e.g.,recovery from acute blood loss,| \n",
      "| (e.g. carbamylated Hb in patients    | hemolytic anemia, HbSS, HbCC, and HbSC)  |\n",
      "| with renal failure) can affect the   | will falsely lower HbA1c test results    |\n",
      "| accuracy of HbA1c measurements       | regardless of the assay method used.Iron | \n",
      "|                                      | deficiency anemia is associated with     | \n",
      "|                                      | higher HbA1c                             |\n",
      " ---------------------------------------------------------------------------------\n",
      "*439854467*\n",
      ".\n",
      "Page 6 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      ":Collected at            :Processed at             LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector 18, \n",
      "ROHINI\n",
      "DELHI 110085LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "GLUCOSE, FASTING (F), PLASMA\n",
      "(GOD POD)\n",
      "90.00 Glucose Fasting  70 - 100 mg/dL\n",
      "THYROID PROFILE,TOTAL, SERUM\n",
      "(CLIA)\n",
      "2.00 T3, Total  0.60 - 1.81 ng/mL\n",
      "4.00 T4, Total  5.01 - 12.45 µg/dL\n",
      "4.00 TSH  0.550 - 4.780 µIU/mL\n",
      "Note\n",
      "1.TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a \n",
      "minimum between 6-10 pm . The variation is of the order of 50% .  hence time of the day has \n",
      "influence on the measured serum TSH concentrations.\n",
      "2.Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or \n",
      "Total T4 levels especially in pregnancy and in patients on steroid therapy.\n",
      "3.Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate \n",
      "more closely with clinical status of the patient than total T4/T3 concentration\n",
      "4.Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH   variant in \n",
      "some individuals\n",
      "*439854467*\n",
      ".\n",
      "Page 7 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085: :Collected at            Processed at             LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "VITAMIN B12; CYANOCOBALAMIN, SERUM\n",
      "(CLIA)280.00 pg/mL 211.00 - 911.00\n",
      "Notes\n",
      "1.Interpretation of the result should be considered in relation to clinical circumstances.\n",
      "2.It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or \n",
      "plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical \n",
      "suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is \n",
      "more specific\n",
      "3.False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking \n",
      "antibodies, MMA measurement should be considered in such patients\n",
      "4.The concentration of Vitamin B12 obtained with different assay methods cannot be used \n",
      "interchangeably due to differences in assay methods and reagent specificity\n",
      "VITAMIN D, 25 - HYDROXY, SERUM\n",
      "(CLIA)85.00 nmol/L 75.00 - 250.00\n",
      "Interpretation \n",
      " -------------------------------------------------------------\n",
      "| LEVEL         | REFERENCE RANGE | COMMENTS                  |\n",
      "|               | IN nmol/L       |                           |\n",
      "|---------------|-----------------|---------------------------|\n",
      "| Deficient     | < 50            | High risk for developing  |\n",
      "|               |                 | bone disease              |\n",
      "|---------------|-----------------|---------------------------|\n",
      "| Insufficient  | 50-74           | Vitamin D concentration   |\n",
      "|               |                 | which normalizes          |\n",
      "|               |                 | Parathyroid hormone       |\n",
      "|               |                 | concentration             |\n",
      "|---------------|-----------------|---------------------------|\n",
      "| Sufficient    | 75-250          | Optimal concentration     | \n",
      "|               |                 | for maximal health benefit|\n",
      "|---------------|-----------------|---------------------------|\n",
      "| Potential     | >250            | High risk for toxic       |\n",
      "| intoxication  |                 | effects                   |\n",
      " -------------------------------------------------------------\n",
      "Note  \n",
      "·The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.\n",
      "·25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.\n",
      "·Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.\n",
      "PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)\n",
      "*439854467*\n",
      ".\n",
      "Page 8 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085: :Collected at            Processed at             LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "·It shows seasonal variation, with values being 40-50% lower in winter than in summer. \n",
      "·Levels vary with age and are increased in pregnancy. \n",
      "·A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available\n",
      "Comments\n",
      "Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency \n",
      "in children causes Rickets and in adults leads to Osteomalacia.  It can also lead to Hypocalcemia and \n",
      "Tetany.  Vitamin D status is best determined  by measurement of 25 hydroxy vitamin D, as it is the major \n",
      "circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).\n",
      "Decreased Levels\n",
      "·Inadequate exposure to sunlight\n",
      "·Dietary deficiency\n",
      "·Vitamin D malabsorption\n",
      "·Severe  Hepatocellular disease\n",
      "·Drugs like Anticonvulsants\n",
      "·Nephrotic syndrome\n",
      "Increased levels\n",
      "Vitamin D intoxication \n",
      "PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)\n",
      "*439854467*\n",
      ".\n",
      "Page 9 of 10\n",
      "Report Status    Male30 Years:\n",
      ":\n",
      ":\n",
      ":Age\n",
      "Gender\n",
      "Reported        \n",
      "P14/5/2023  11:03:00AMU439854467   DUMMY:\n",
      ":\n",
      ":\n",
      ":\n",
      ":Name        \n",
      "Lab No.    \n",
      "Ref By \n",
      "Collected       \n",
      "A/c Status 16/5/2023  1:36:25PM\n",
      "Final\n",
      "LPL-NATIONAL REFERENCE LAB\n",
      "National Reference laboratory, Block E, \n",
      "Sector 18, Rohini, New Delhi -110085: :Collected at            Processed at             LPL-ROHINI (NATIONAL REFERENCE LAB)\n",
      "National Reference laboratory, Block E, Sector \n",
      "18, ROHINI\n",
      "DELHI 110085\n",
      "Test Report      \n",
      "Test Name Results Units Bio. Ref. Interval\n",
      "Dr Ajay Gupta\n",
      "MD, Pathology\n",
      "Technical Director - Hematology & \n",
      "Immunology                                      \n",
      "NRL - Dr Lal PathLabs LtdDr Gurleen Oberoi\n",
      "DM(Hematopathology), MD, \n",
      "DNB,MNAMS\n",
      "Consultant & Technical Lead \n",
      "-Hematopathology                                        \n",
      "NRL - Dr Lal PathLabs LtdDr Himangshu Mazumdar\n",
      "MD, Biochemistry\n",
      "Sr. Consultant Biochemist                                               \n",
      "NRL - Dr Lal PathLabs LtdDr  Jatin Munjal\n",
      "MD,Pathology\n",
      "Consultant Pathologist                          \n",
      "Dr Lal PathLabs Ltd\n",
      "Dr Sarita Kumari Lal\n",
      "MD, Pathology\n",
      "Consultant Pathologist                          \n",
      "Dr Lal PathLabs LtdDr Sunanda\n",
      "MD, Pathology\n",
      "Consultant Pathologist                          \n",
      "Dr Lal PathLabs Ltd\n",
      "Dr Nimmi Kansal\n",
      "MD, Biochemistry\n",
      "Technical Director - Clinical \n",
      "Chemistry & Biochemical Genetics                    \n",
      "NRL - Dr Lal PathLabs LtdDr.Kamal Modi\n",
      "MD, Biochemistry\n",
      "Consultant Biochemist                                                   \n",
      "NRL - Dr Lal PathLabs Ltd\n",
      "-------------------------------End of report --------------------------------\n",
      "AHEEEHAPMKHJBIFNLKIPAPNCBILLJCECCJLCIKPLNKEDFBFAPPAHEEEHA\n",
      "BNFFFNBPAPBLJHFGFGEKFOIPAOAHFHALBOJOBCJCJLEKMGJHNPBNFFFNB\n",
      "CIEGFGFNNNOJPBFOPFIAAJHFJCHEHEDBPKPHENFLMLKIOEFLBKHDEHANP\n",
      "DJMBGAFNBHOIEDIAPLOELFMFAFHLBLBFJIFEPBPAKCLJPDNLIFNBKEMEK\n",
      "KBMKLHFJONJFDIAMDMACKPJADENNOJCHKKMLAMMIPLKGKPNGKFFFOLMNG\n",
      "HGCBBEFNNICGDLHKIPAADIPBADHFOFAINDFCBKDLALIKOMNALNEIOGMKD\n",
      "DPIMIJFJALOBFHEIEKMBJEGHIHAFJBAKOHOPBLMIIJCHKJNLIJNFIDILD\n",
      "NJJJAMFNAINEBIHJGANHDMEILLBMFMBBKFCCAMNNIIKNOPNKBNFMBHILL\n",
      "NKLOFFFPCDCGFAAIONMIHIMKHGFFEKFBJFFLALPFOOBIOCNKDJPHNEKLJ\n",
      "PPNNOPFCEPFJJDCKJKAFGPNKADFKPNJHKEPFGBHLNKCKIGEOCNKKHMAMK\n",
      "LAIKOLFLGKCBMOCMPFNHEJEEINMFPAFBJMFEBFOFPNDMKPFKEPCIGCAEO\n",
      "MOICGJFCPLDGKEIMHHGNMMDEIEOPPFOEBEFPBLNOOLJBIKNJNKONHDICL\n",
      "MNNNNNEPKFDPBCCJOCFLHACHJBAHFHAHJKPFCMNLMKJCLFNMAHFHAHIKL\n",
      "APBBBPAPBBAAEJBCFMDKCBCFAGECHHCAONFFOLPGOLMHNLNNEDFHHBKHH\n",
      "HHHHHHHPHPPPHPPPPPPPPPHHPHPPPPPPPPPHHPPPPHHHPHPHHHHHPHPHP\n",
      "IMPORTANT INSTRUCTIONS\n",
      "ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory . \n",
      "ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport \n",
      "delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for \n",
      "derivation of exact value. Kindly submit request within 72 hours post reporting .ŸTest results may show interlaboratory variations .ŸThe Courts /Forum \n",
      "at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test (s) & or results of test (s).ŸTest results are not valid for medico legal \n",
      "purposes. ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor. ŸThe report does \n",
      "not need physical signature.\n",
      "(#) Sample drawn from outside source.\n",
      "If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action. \n",
      "Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com \n",
      "National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.\n",
      "PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)\n",
      "*439854467*\n",
      ".\n",
      "Page 10 of 10\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import PyPDF2  # Import PyPDF2 for PDF processing\n",
    "\n",
    "def extract_text_from_pdf(pdf_path):\n",
    "    # empty string to store extracted text\n",
    "    text = \"\"\n",
    "    pdf_reader = None\n",
    "\n",
    "    try:\n",
    "        # open the file \n",
    "        pdf_reader = PyPDF2.PdfReader(pdf_path)\n",
    "\n",
    "    except PyPDF2.errors.PdfReaderError as e:\n",
    "        print(f\"Error reading PDF: {e}\")\n",
    "        return text\n",
    "\n",
    "    # go through the each page in file \n",
    "    for page_num in range(len(pdf_reader.pages)):\n",
    "        page = pdf_reader.pages[page_num]\n",
    "\n",
    "        # try to extract text directly \n",
    "        try:\n",
    "            extracted_text = page.extract_text() # extract \n",
    "            text += extracted_text # add it to the total text\n",
    "        except:\n",
    "            pass\n",
    "        \n",
    "        # if text extraction fails, we should use OCR as that would be the image in the pdf \n",
    "        if not extracted_text:\n",
    "            try:\n",
    "                # temp image file path\n",
    "                image_path = f\"{pdf_path[:-4]}-{page_num}.jpg\"\n",
    "                # Open the PDF page as an image\n",
    "                image = Image.open(image_path)\n",
    "\n",
    "                # OCR \n",
    "                extracted_text = pytesseract.image_to_string(image)\n",
    "                # append \n",
    "                text += extracted_text\n",
    "\n",
    "            except Exception as e: \n",
    "                print(f\"Error during OCR: {e}\")\n",
    "            finally:\n",
    "                # clean \n",
    "                if os.path.exists(image_path):\n",
    "                    os.remove(image_path)\n",
    "\n",
    "    return text\n",
    "\n",
    "pdf_path = \"../Dummy_Medical_report/WM17S.pdf\"\n",
    "extracted_text = extract_text_from_pdf(pdf_path)\n",
    "\n",
    "print(extracted_text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "env_ai",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
